Article
Compositional editing of extracellular matrices by CRISPR/Cas9 engineering of human…
medRxiv · 2024 · Prithiviraj, S.; Garcia Garcia, A.; Linderfalk, K.; Yiguang, B.; Ferveur, S.; Falck, L. N.; Subramaniam, A.; Mohlin, S.; Gil, D. H.; Dupard, S. J.; Raina, D. B.; Bourgine, P. E.
Key facts
| Title | Compositional editing of extracellular matrices by CRISPR/Cas9 engineering of human mesenchymal stem cell lines |
|---|---|
| First author | Prithiviraj, S.; Garcia Garcia, A.; Linderfalk, K.; Yiguang, B.; Ferveur, S.; Falck, L. N.; Subramaniam, A.; Mohlin, S.; Gil, D. H.; Dupard, S. J.; Raina, D. B.; Bourgine, P. E. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2023.07.28.550935 |
| Devices mentioned | N17600, P800002 |
| Product codes mentioned | LMF, MVU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1